investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Risk Prediction for ER Negative Breast Cancer Recurrence
Melissa L Bondy
3 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
A C Matin
HER2-targeted exosomal delivery of therapeutic mRNA for enzyme pro-drug therapy
Breast
Global Noncommunicable Diseases Intiatives
Assistance to Civil Society Organizations in Palestine - Phase IV: Al-Basma Center for Audio and Communication
Breast
Sarah J Nechuta
Modifiable Lifestyle-Related Factors and Triple Negative Breast Cancer Prognosis
Breast
Christopher A Haiman
Genome-Wide Association Study of Breast Cancer in High-Risk Women
Breast
Philip Lazarus
Role of Pharmacogenetics on Exemestane Metabolism and Toxicity
Breast
Global Noncommunicable Diseases Intiatives
Mammography Installation Project
Breast
Naoto Ueno
Targeting the Variant Form of CD44 in Triple-Negative and Inflammatory Breast Cancer
Breast
Global Noncommunicable Diseases Intiatives
Funding for exchange of scientists - 8
Breast
Needs Assessment to Assess Barriers to Developing a Comprehensive Cancer Center in LMICs
Breast